Quick summary

Bacillus licheniformis is a bacterial species classified as a probiotic and postbiotic supplement. It has been studied for potential effects on gut microbiota and intestinal health, but current evidence on human benefits and safety is still under research. There are no authorized health claims by the European Union specifically for Bacillus licheniformis at this time. Dosage and safety guidelines have yet to be established, and high-quality clinical evidence remains limited.

What is it?

Bacillus licheniformis is a spore-forming bacterium used as a probiotic supplement aimed at modulating the gut microbiota and supporting digestive health. As a member of the genus Bacillus, it is naturally found in soil and various environmental sources. The supplement form of Bacillus licheniformis is intended to deliver live bacterial spores that may exert health-related effects through interaction with the intestinal environment.

How it may work in the body

As a probiotic, Bacillus licheniformis may influence gut microbial balance and intestinal function through several proposed mechanisms:

  • Modulation of gut microbiota composition to promote a healthier microbial ecosystem
  • Competitive exclusion of pathogenic bacteria by outcompeting them for nutrients and adhesion sites
  • Production of enzymes or metabolites that create a beneficial gut environment

These mechanisms are based on general probiotic principles. However, direct evidence specific to Bacillus licheniformis, particularly in human studies, is limited or pending. Thus, while plausible, the precise biological effects remain under investigation.

Common supplement forms

The supplied evidence did not specify common supplement forms for Bacillus licheniformis. Typically, probiotic supplements may be available as capsules, powders, or tablets containing spores or live bacterial cultures, but form-specific information is not available.

Typical dosage and how it is used

Dosage summary: There is no standardized or established typical dosage for Bacillus licheniformis supplementation from the available evidence at this time.

Study dosages: No specific clinical trial dosages were supplied.

Official intake: There is no official recommended daily intake (RDA) or adequate intake (AI) guideline for Bacillus licheniformis.

Caution: Due to limited research and absence of established dosage guidelines, caution is advised when considering Bacillus licheniformis supplementation. Consultation with a healthcare professional is recommended.

Natural sources

There are no identified natural dietary sources of Bacillus licheniformis relevant to food consumption. It is primarily obtained through supplementation if used.

Absorption and bioavailability

Bacillus licheniformis is a spore-forming bacterium recognized for its ability to survive harsh conditions of the gastrointestinal tract, such as stomach acid and bile salts. These spores can potentially germinate and exert probiotic effects once reaching the intestines.

Specific data on the absorption, colonization, or bioavailability parameters of Bacillus licheniformis spores in humans are not available in the current evidence.

Potential benefits: what does the evidence say?

Gut microbiota modulation and intestinal health

Early-stage research and preliminary studies are investigating Bacillus licheniformis for its potential to modulate the gut microbiota and support intestinal health. However, well-controlled and completed human clinical trials are lacking, resulting in insufficient evidence to draw firm conclusions.

Current human evidence remains limited, and definitive benefits have not been established.

Side effects and safety

There is limited information regarding common side effects, contraindications, or adverse events related to Bacillus licheniformis supplementation in humans. Safety data, including effects linked to toxicity or overuse, have not been established.

No specific safety concerns or quality-related issues are reported in the supplied evidence, but the overall data remain incomplete.

Drug and supplement interactions

No documented drug or supplement interactions are available for Bacillus licheniformis based on the current evidence.

Who should be careful?

Given limited safety data, individuals with underlying health conditions, compromised immune systems, or those receiving immunosuppressive therapies should exercise caution. Consulting a healthcare professional prior to use is advisable.

Pregnancy, breastfeeding and special populations

No evidence is available to assess the safety of Bacillus licheniformis during pregnancy or breastfeeding. Similarly, data for use in children, elderly, or other special populations are insufficient. Consultation with a healthcare provider is recommended before use in these groups.

Quality, standardization and what to look for

Because Bacillus licheniformis supplements are not regulated with established standards, product quality can vary. Consumers should seek products from reputable manufacturers that provide information on bacterial strain identification, viability, and manufacturing quality control. Certificates of analysis or third-party testing may add assurance.

Frequently asked questions

  • Is Bacillus licheniformis the same as other probiotics? Bacillus licheniformis is one species among many probiotic bacteria. It is spore-forming, which may offer advantages in surviving stomach acid, but it is distinct from more commonly used species like Lactobacillus or Bifidobacterium.
  • Are there EU-authorized health claims for Bacillus licheniformis? Currently, there are no European Union authorized health claims specifically for Bacillus licheniformis supplementation.
  • Can Bacillus licheniformis cure digestive issues? There is no evidence to support that Bacillus licheniformis treats, cures, or prevents any digestive or other diseases.
  • How should I take Bacillus licheniformis supplements? Due to lack of established dosage guidelines and limited safety data, it is best to consult a healthcare professional before starting supplementation.
  • Are Bacillus licheniformis spores found in food? No common dietary sources are known; typically, the bacterium is consumed through supplements.

Evidence limitations

  • Research on Bacillus licheniformis is currently pending with no completed or high-quality systematic reviews or definitive human clinical trials available.
  • There are no official regulatory sources or intake guidelines for this bacterium as a supplement.
  • Safety and efficacy data in humans are not sufficiently documented, limiting conclusive statements about benefits or risks.

References

Last reviewed

June 2024

Disclaimer: This page provides information based on current research available as of the last review date. It is not intended to diagnose, treat, cure, or prevent any disease. People who are pregnant, breastfeeding, have medical conditions, use medication, or are planning surgery should consult a qualified healthcare professional before using any supplement.